Clinical Trials Logo

Filter by:
NCT ID: NCT05121688 Completed - COVID-19 Clinical Trials

Effectiveness of a Physical Therapy Telerehabilitation Program in Long Post COVID-19 Symptoms in Primary Health Care.

TPhysioCovid
Start date: November 25, 2021
Phase: N/A
Study type: Interventional

The evolution of Coronavirus disease 2019 (COVID-19) pandemic makes it more necessary the intervention of Primary Health Care Physiotherapy Units in patients with respiratory and/or functional sequelae after suffering from SARS-CoV-2 (acute respiratory sindrome by coronavirus) virus infection. Since some months ago, Primary Health Care use telerehabilitation tools to connect patients and health care professions while maintaining social distancing and restrictions. Tele-physiotherapy is a field of physiotherapy which has the advantage of providing physical therapy interventions to patients' complications after COVID-19 by using a videoconferencing method. The aim of this study is to evaluate the effectiveness of a multimodal Physical Therapy telerehabilitation program in persistent post COVID-19 symptoms in Primary Health Care.

NCT ID: NCT05121181 Completed - Cholelithiasis Clinical Trials

Reaching Consensus on the Definition of Difficult Cholecystectomy

Start date: July 1, 2020
Phase:
Study type: Observational

Being able to predict the difficulty of a preoperatively can increase safety and improve results. However, a consensus must be reached regarding the definition of a cholecystectomy as "difficult". The aim of this study is to achieve a national expert consensus. Methods A Delphi study was conducted. Based on the literature, a history of biliary pathology, preoperative clinical, analytical, and radiological data, and intraoperative findings were selected and rated on a Likert scale. Inter-rater agreement was defined as "unanimous" when 100% of the participants gave an item the same the Likert scale rating; as "consensus" when ≥80% agreed; as "majority" when the agreement was ≥70%.

NCT ID: NCT05120479 Completed - Healthy Volunteers Clinical Trials

Effects of Taping on the Proprioceptive System

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

Kinesiotape (KT) is a widely used technique, although the scientific evidence on its effectiveness is limited and conflicting. KT has not yet been scientifically proven to have an effect on proprioception and a possible placebo effect of this technique cannot be ruled out. The main objective of this experimental study is to evaluate the effect of the application of KT in the anterior side of the forearm on the force sense and the positional sense compared to a placebo intervention in healthy subjects. A randomized, single-blind, crossover clinical trial will be carried out, where each subject will undergo three situations in their dominant forearm: no intervention, intervention using sham tape and intervention using KT. In the present design, in a randomized manner, all subjects go through the 3 conditions on different days: KT, sham tape, and no intervention. Measurements will be made before and after the intervention and proprioception will be measured using the variables of sense of force (with a dynamometer) and joint position (with a goniometer). The main intervention will be the application of a KT strip on the anterior face of the forearm and a sham tape of another material following the same procedure. The study population will be made up of healthy students from the university community of the Faculty of Physiotherapy of the University of Vigo. The main objective of this experimental study is to evaluate the effect of the application of kinesiotape (KT) in the anterior side of the forearm on the force sense and the joint positional sense of the wrist compared to a placebo/sham intervention in healthy subjects. Study hypothesis: the application of KT on the anterior side of the forearm produces better results in the force sense evaluated by a grip dynamometry and on the joint position sense of the wrist compared to a sham intervention or not intervention.

NCT ID: NCT05118659 Completed - Vertigo Clinical Trials

Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo

Start date: February 3, 2018
Phase: N/A
Study type: Interventional

This analysis aims to evaluate the immediate effect that cervical sustained natural apophyseal glides (SNAGs) have on a group of individuals with induced vertigo by a caloric vestibular stimulation.

NCT ID: NCT05117203 Completed - Healthy Clinical Trials

Dynamic Electrostimulation on the Abdominal Muscles in Healthy Individuals

Start date: November 11, 2021
Phase: N/A
Study type: Interventional

To determine the immediate effects on the abdominal musculature, assessed by ultrasound (RUSI), due to the application of electrostimulation using whole body electrostimulation together with physical exercise in healthy people and to compare with the application of local EMS in the abdominal area and the same physical exercise session. The same intervention is carried out for the control group as the WB-EMS group but simulated.

NCT ID: NCT05117060 Completed - Atopic Dermatitis Clinical Trials

Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis

Start date: December 13, 2021
Phase: Phase 2
Study type: Interventional

This is an up to 22-week clinical study in adult participants with moderate to severe atopic dermatitis (AD). The purpose of the study is to test a new tablet (LEO 152020) to see if it improves AD and what the side effects are when compared with a placebo tablet with no medical ingredient. During the study, there will be a 16-week treatment period during which the participants will be asked to take the tablets. The participants will regularly visit the clinic for tests and the study doctor will evaluate their AD. The participants will also be asked to answer questions about their AD symptoms, itch, sleep, and quality of life.

NCT ID: NCT05116982 Completed - Clinical trials for Biological Availability

Effect of Three Silicon Based Food Supplements on the Urinary Excretion of Aluminum and Other Metals (SILIAL)

SILIAL
Start date: May 9, 2022
Phase: N/A
Study type: Interventional

Aluminum is a very abundant element in nature. Humans are exposed to this metal through the environment, diet, and drinking water, as well as through the consumption of certain medications. Aluminum is not an essential element for human, being able to become neurotoxic when it reaches the brain once ingested at very high doses and, above all, if there is also kidney dysfunction. Silicon is one of the most abundant elements on the planet and although it is not considered an essential element for humans, some beneficial activities have been documented. Silicon has been found to be readily available in food and that 41% of ingested silicon is excreted in the urine, with a significant correlation between silicon ingested with food and urinary silicon excretion. The most bioavailable silicon is that found in the form of silicic acid or orthosilicic acid. Numerous studies suggest that silicon can reduce the oral absorption of aluminum and / or improve its excretion and, therefore, protect against the adverse effects induced by the ingestion of aluminum. In a clinical study with healthy individuals as a control group for Alzheimer's disease, the levels of aluminum excretion were analyzed after the continuous ingestion of water enriched in silicon. The results in the first urine of the morning during the first week of ingestion of the enriched water showed that the excretion of aluminum was 136.9 ± 81.4 µmol / nmol creatinine while in the baseline week it was lower, 98.8 ± 64.3 nmol / nmol creatinine. These results indicated that the Al excreted came from Al stored in the body. The main objective of the study is to evaluate the effect of the consumption of three food supplements formulated with different silicon compounds (monomethylsilanetriol and / or silicic acid) on the urinary excretion of aluminum. The secondary objectives of the study are to evaluate: - the bioavailability of the silicon contained in three food supplements formulated with different silicon compounds. - the effect of the consumption of three food supplements formulated with different silicon compounds on urinary excretion of mercury, nickel, arsenic, cadmium, iron and copper. - the safety of the consumption of three food supplements formulated with different silicon compounds.

NCT ID: NCT05116891 Completed - Colorectal Cancer Clinical Trials

A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors

Start date: September 22, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase 1/2, open-label, multicentric, non-randomised, parallel-arm study that aims to establish the safety, tolerability, and initial efficacy of CAN04 in combination with 3 SoC chemotherapies (mFOLFOX, DTX, and G/C).

NCT ID: NCT05116202 Completed - Melanoma Clinical Trials

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma)

Start date: February 2, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This study will evaluate the efficacy, safety, and pharmacokinetics of treatment combinations in cancer immunotherapy (CIT)-naive participants with resectable Stage III melanoma (Cohort 1) and in participants with Stage IV melanoma (Cohort 2). The study is designed with the flexibility to open new treatment arms as new treatments become available, close existing treatment arms that demonstrate minimal clinical activity or unacceptable toxicity, and modify the participant population.

NCT ID: NCT05115604 Completed - Schizophrenia Clinical Trials

Insomnia in the Patient With Schizophrenic Disorder: Evaluation of a CBT and Psychoeducational Intervention

Start date: April 8, 2021
Phase: N/A
Study type: Interventional

The study aims to evaluate the efficacy of a cognitive behavioural and psychoeducational intervention in patients with insomnia and diagnosed with a schizophrenic disorder.